WEBVTT - Targeting the Toughest Diseases (Sponsored Content)

0:00:00.680 --> 0:00:04.240
<v Speaker 1>I'm Edward Adams of Bloomberg Media Studios. Since you're a

0:00:04.280 --> 0:00:07.440
<v Speaker 1>subscriber to Bloomberg Business Week, we thought you'd be interested

0:00:07.440 --> 0:00:11.840
<v Speaker 1>in a new six episode sponsored content podcast called Targeting

0:00:11.840 --> 0:00:15.680
<v Speaker 1>the Toughest Diseases. It shows how the battle against some

0:00:15.720 --> 0:00:19.680
<v Speaker 1>of humanity's most challenging diseases is happening at the intersection

0:00:19.880 --> 0:00:25.360
<v Speaker 1>of business and medicine. The podcast explores how Vertex Pharmaceuticals,

0:00:25.680 --> 0:00:30.240
<v Speaker 1>a Boston based biotech company, is using innovative tools, methods,

0:00:30.480 --> 0:00:34.880
<v Speaker 1>and a unique philosophy to search for treatments and cures.

0:00:35.280 --> 0:00:39.159
<v Speaker 1>Produced by Bloomberg Media Studios and sponsored by Vertex, the

0:00:39.200 --> 0:00:44.400
<v Speaker 1>podcast's latest episode features NBA great Alonzo Mourning, recounting his

0:00:44.440 --> 0:00:48.040
<v Speaker 1>fight against kidney disease and how scientists are working hard

0:00:48.440 --> 0:00:52.440
<v Speaker 1>to provide hope for future generations of patients. You can

0:00:52.479 --> 0:00:57.240
<v Speaker 1>subscribe today on Apple Podcasts, Spotify, or wherever you listen

0:00:57.280 --> 0:01:05.720
<v Speaker 1>to your favorite podcasts. Here's the full EPISO showed Miami

0:01:05.760 --> 0:01:11.640
<v Speaker 1>Arena March, the Miami Heat are facing the Washington Bullets

0:01:13.959 --> 0:01:16.720
<v Speaker 1>all night long. Alonso Morning of the Heat has been

0:01:16.720 --> 0:01:19.920
<v Speaker 1>guarded by a giant of a man named George Morrisson.

0:01:20.720 --> 0:01:23.720
<v Speaker 1>At seven ft seven. Morrisson is one of the fiercest

0:01:23.760 --> 0:01:26.880
<v Speaker 1>players in the league, the tallest player in NBA history,

0:01:27.280 --> 0:01:34.559
<v Speaker 1>an impenetrable wall with a NonStop motor, but Alonso Morning

0:01:34.840 --> 0:01:36.839
<v Speaker 1>is one of the greatest ever to step on the court.

0:01:40.200 --> 0:01:42.760
<v Speaker 1>When the final buzzer goes, the Heat have won a

0:01:42.840 --> 0:01:45.840
<v Speaker 1>hundred and twelve to ninety three, and Morning has scored

0:01:45.840 --> 0:01:49.680
<v Speaker 1>an incredible fifty points. That game was a career high

0:01:49.760 --> 0:01:52.120
<v Speaker 1>from Morning. He would go on to be a seven

0:01:52.160 --> 0:01:54.560
<v Speaker 1>time All Star and a gold medalist in the two

0:01:54.600 --> 0:01:58.880
<v Speaker 1>thousand Olympics. But little did he know his toughest opponent

0:01:59.120 --> 0:02:03.600
<v Speaker 1>was yet to come. After returning from the Olympics in Sydney,

0:02:03.840 --> 0:02:07.760
<v Speaker 1>Morning started into his usual offseason training, but he noticed

0:02:07.880 --> 0:02:13.400
<v Speaker 1>something was wrong. I was experiencing lethargy, a dima and

0:02:13.520 --> 0:02:20.119
<v Speaker 1>my legs swelling in my lower extremities. Extremely tired, worn out.

0:02:21.040 --> 0:02:24.000
<v Speaker 1>He thought it was jet lag, maybe the flu. He

0:02:24.120 --> 0:02:26.440
<v Speaker 1>figured he'd just take a couple of days off then

0:02:26.520 --> 0:02:30.240
<v Speaker 1>resume his training. His doctor had a different idea. He

0:02:30.360 --> 0:02:33.720
<v Speaker 1>suggested they run some tests. I answered the phone next

0:02:33.720 --> 0:02:36.919
<v Speaker 1>to the bit and he said, you know, I got

0:02:36.960 --> 0:02:42.000
<v Speaker 1>your results back. He said that you've got this rare

0:02:43.280 --> 0:02:48.760
<v Speaker 1>genetic disorder called focal segmental glamorio los carrosis, and I said, Doc,

0:02:48.840 --> 0:02:51.000
<v Speaker 1>what is that? He said, It's a disease that scars

0:02:51.040 --> 0:02:55.040
<v Speaker 1>the filters in the kidney. Focal Segmental glamoryo losclerosis, or

0:02:55.200 --> 0:02:57.840
<v Speaker 1>f s GS caused a scar tissue to develop on

0:02:57.880 --> 0:03:00.040
<v Speaker 1>the small parts of the kidneys that filter waste in

0:03:00.120 --> 0:03:04.400
<v Speaker 1>the blood. I asked them three questions. I said, is

0:03:04.440 --> 0:03:09.760
<v Speaker 1>there a cure forness? He said no. I said, can

0:03:09.800 --> 0:03:15.280
<v Speaker 1>I play basketball again? He said, I don't know? And

0:03:15.320 --> 0:03:26.880
<v Speaker 1>then I said, WHOA am I gonna die? Hi? I'm

0:03:26.960 --> 0:03:29.720
<v Speaker 1>Jordan's gospel A. I'm a member of the University of

0:03:29.760 --> 0:03:33.400
<v Speaker 1>Southern California's Center for Health Journalism. This is Targeting the

0:03:33.400 --> 0:03:37.560
<v Speaker 1>Toughest Diseases a podcast produced by Bloomberg Media Studios and

0:03:37.640 --> 0:03:41.280
<v Speaker 1>Vertex Pharmaceuticals. In this series, we look at some of

0:03:41.360 --> 0:03:45.640
<v Speaker 1>humanity's most challenging diseases and how Vertex, a Boston based

0:03:45.640 --> 0:03:49.760
<v Speaker 1>biotech company, is using innovative tools, methods, and a unique

0:03:49.760 --> 0:03:54.840
<v Speaker 1>philosophy to search for treatments and cures. Today, we're looking

0:03:54.880 --> 0:03:58.280
<v Speaker 1>at APO l one mediated kidney disease, a disease caused

0:03:58.280 --> 0:04:03.080
<v Speaker 1>by a genetic abnormality. One of African Americans carry this

0:04:03.200 --> 0:04:06.320
<v Speaker 1>oftermality can cause a number of types of kidney diseases,

0:04:06.760 --> 0:04:09.880
<v Speaker 1>one of which is f SGS, the condition Alonso Morning

0:04:10.000 --> 0:04:17.560
<v Speaker 1>was diagnosed with. I thought to myself, not why me,

0:04:18.480 --> 0:04:22.279
<v Speaker 1>but why right now? God? Why am I dealing with

0:04:22.320 --> 0:04:25.360
<v Speaker 1>this right now of all times. I had just come

0:04:25.400 --> 0:04:28.599
<v Speaker 1>back from the Sydney, Australia Olympics winning the gold medal,

0:04:29.000 --> 0:04:31.719
<v Speaker 1>had just come off an amazing basketball season where I

0:04:31.760 --> 0:04:36.000
<v Speaker 1>had First Team All NBA All Star Team. The list

0:04:36.080 --> 0:04:40.640
<v Speaker 1>goes on, you know, all the accolades, and then all

0:04:40.640 --> 0:04:43.880
<v Speaker 1>of a sudden, bam. This happens. Lots of young professional

0:04:43.920 --> 0:04:49.000
<v Speaker 1>athletes view themselves as invincible. Alonso suddenly found out he wasn't.

0:04:49.440 --> 0:04:52.320
<v Speaker 1>All of the phone and my face fell in my hands.

0:04:54.480 --> 0:04:56.160
<v Speaker 1>I felt like I was gonna play until I was

0:04:56.200 --> 0:04:58.520
<v Speaker 1>in my forties because I was in such great shape.

0:04:58.960 --> 0:05:02.400
<v Speaker 1>Just airing from somebody saying hey, you gotta stop playing.

0:05:02.400 --> 0:05:05.839
<v Speaker 1>It was humbling and he was deflating, you know, and

0:05:05.920 --> 0:05:09.280
<v Speaker 1>I just was just sitting there just trying to figure out, Okay,

0:05:09.600 --> 0:05:17.279
<v Speaker 1>how is this all going to materialize? We can't survive

0:05:17.320 --> 0:05:20.839
<v Speaker 1>without our kidneys. They play a vital role. They help

0:05:20.880 --> 0:05:25.400
<v Speaker 1>our bodies maintain just the right balance of electrolytes like potassium,

0:05:25.440 --> 0:05:29.240
<v Speaker 1>They control blood pressure, the cleaner blood, and they even

0:05:29.240 --> 0:05:32.800
<v Speaker 1>help maintain our hormone levels. Each kidney is made up

0:05:32.880 --> 0:05:36.120
<v Speaker 1>of a million or so tiny filters called gloomy uli

0:05:36.839 --> 0:05:40.520
<v Speaker 1>They're like little coffee filters. The filtered liquid becomes urine

0:05:40.800 --> 0:05:43.279
<v Speaker 1>and the protein left behind stays in our blood. But

0:05:43.320 --> 0:05:47.120
<v Speaker 1>when the gloomeryulie become damaged, those proteins start leaking into

0:05:47.200 --> 0:05:50.600
<v Speaker 1>the urine. The scary thing is it's estimated thirty seven

0:05:50.640 --> 0:05:53.560
<v Speaker 1>million adults in the United States have kidney disease, and

0:05:53.800 --> 0:05:56.040
<v Speaker 1>ninety percent of them don't even know they have it.

0:05:56.680 --> 0:05:58.760
<v Speaker 1>And in the case of a po l one mediated

0:05:58.800 --> 0:06:03.520
<v Speaker 1>kidney disease, the prime causal factor is invisible. It's genetic

0:06:04.000 --> 0:06:10.920
<v Speaker 1>caused re mutations in the a po l one gene.

0:06:11.880 --> 0:06:14.960
<v Speaker 1>Back in the early nineteen nineties, Dr David Friedman, a

0:06:15.040 --> 0:06:18.719
<v Speaker 1>doctor researcher and an associate professor with Harvard Medical School

0:06:18.800 --> 0:06:21.800
<v Speaker 1>who currently works with Vertex on its clinical trials, first

0:06:21.800 --> 0:06:25.200
<v Speaker 1>started to notice something unusual. He was seeing African American

0:06:25.240 --> 0:06:29.880
<v Speaker 1>families where multiple members all had kidney disease. When there's

0:06:29.880 --> 0:06:33.279
<v Speaker 1>an important inherited component of a disease, it tends to

0:06:33.320 --> 0:06:37.240
<v Speaker 1>cluster in families. Understanding there was a genetic cause was

0:06:37.360 --> 0:06:40.560
<v Speaker 1>just the beginning. Next, they had to find the exact gene.

0:06:42.960 --> 0:06:46.159
<v Speaker 1>I think a real breakthrough in our understanding came in

0:06:46.240 --> 0:06:49.440
<v Speaker 1>two thousand and eight when some teams at Johns Hopkins

0:06:49.480 --> 0:06:52.520
<v Speaker 1>in the n i H were the first to find

0:06:52.760 --> 0:06:56.200
<v Speaker 1>a location in the geno my chromosome twenty two where

0:06:56.520 --> 0:07:00.120
<v Speaker 1>it became apparent that there was something strong that was

0:07:00.120 --> 0:07:04.920
<v Speaker 1>impacting kidney disease in people of African ancestry. Then Dr

0:07:05.000 --> 0:07:09.120
<v Speaker 1>Friedman and his colleagues identified the specific mutations that led

0:07:09.160 --> 0:07:12.160
<v Speaker 1>to this type of kidney disease. There were two important

0:07:12.280 --> 0:07:18.000
<v Speaker 1>advances in technology which really helped us to pinpoint these

0:07:18.040 --> 0:07:22.400
<v Speaker 1>two genetic variants in April one. The first was related

0:07:22.520 --> 0:07:27.920
<v Speaker 1>to tools for identifying positive selection in the genome, and

0:07:28.040 --> 0:07:33.240
<v Speaker 1>these these mathematical tools helped us envisioned the genome in

0:07:33.280 --> 0:07:37.440
<v Speaker 1>a slightly different way. In the second major technological advance

0:07:38.160 --> 0:07:43.800
<v Speaker 1>was a database of genetic variants in people of widely

0:07:43.880 --> 0:07:47.440
<v Speaker 1>diverse ancestry, is called the Thousand Genomes project. Up until

0:07:47.480 --> 0:07:50.960
<v Speaker 1>that time, most of what we knew about genetic variation

0:07:51.440 --> 0:07:56.560
<v Speaker 1>came from people of European ancestry, and this new, very

0:07:56.600 --> 0:08:01.440
<v Speaker 1>powerful tool was a really equivalent of an cyclopedia of

0:08:01.720 --> 0:08:06.040
<v Speaker 1>genetic variation around the world. From there, our understanding of

0:08:06.080 --> 0:08:10.640
<v Speaker 1>apoel one has continued to increase, including why the risk

0:08:10.760 --> 0:08:14.640
<v Speaker 1>variants in this gene only affect people of recent African descent,

0:08:14.880 --> 0:08:21.720
<v Speaker 1>including African American, Latin X and Afro Caribbean communities. Thousands

0:08:21.720 --> 0:08:24.680
<v Speaker 1>of years ago, a genetic mutation in the apoel one

0:08:24.720 --> 0:08:29.200
<v Speaker 1>gene developed in sub Saharan Africa as a protective mechanism.

0:08:29.280 --> 0:08:33.200
<v Speaker 1>We all have a gene that encodes for the april

0:08:33.240 --> 0:08:37.720
<v Speaker 1>one protein, but the version which causes kidney disease contains

0:08:37.800 --> 0:08:42.440
<v Speaker 1>some very slight changes in the instructions for building that

0:08:42.559 --> 0:08:47.360
<v Speaker 1>protein that turn out to make it very effective for

0:08:47.640 --> 0:08:52.400
<v Speaker 1>killing the trepanisomes that cause African sleeping sickness and humans.

0:08:53.040 --> 0:08:55.800
<v Speaker 1>Sleeping sickness is a disease spread by the bite of

0:08:55.800 --> 0:08:58.800
<v Speaker 1>an infected fly, and it can cause death within a

0:08:58.840 --> 0:09:02.040
<v Speaker 1>matter of weeks. But this genetic mutation stops it in

0:09:02.120 --> 0:09:06.319
<v Speaker 1>its tracks. Because it was so effective. It's spread very

0:09:06.360 --> 0:09:10.480
<v Speaker 1>quickly in the population, but it's these proteins with a

0:09:10.679 --> 0:09:13.920
<v Speaker 1>slightly different version of april one. It's very very effective

0:09:14.000 --> 0:09:18.240
<v Speaker 1>for killing japanizomes and preventing African sleeping sickness, which is

0:09:18.280 --> 0:09:23.160
<v Speaker 1>the same version of the protein which makes the kidneys

0:09:23.160 --> 0:09:27.360
<v Speaker 1>of people sick who have this genetic variant. We now

0:09:27.440 --> 0:09:30.520
<v Speaker 1>understand that having one a poel one risk variant could

0:09:30.559 --> 0:09:33.120
<v Speaker 1>protect you from many forms of sleeping sickness. But if

0:09:33.200 --> 0:09:36.520
<v Speaker 1>you were unlucky enough to inherit to one from your

0:09:36.559 --> 0:09:39.319
<v Speaker 1>mother and one from your father, your chances of getting

0:09:39.360 --> 0:09:56.360
<v Speaker 1>kidney disease goes up tenfold dore once your kidneys start

0:09:56.440 --> 0:09:58.880
<v Speaker 1>to fail, there really are only a few ways to

0:09:58.920 --> 0:10:02.960
<v Speaker 1>stay alive. One is dialysis. It replaces the function of

0:10:03.000 --> 0:10:07.000
<v Speaker 1>the kidney. Dr Janice Lee studies kidney disorders at Emory

0:10:07.120 --> 0:10:12.679
<v Speaker 1>University School of Medicine in Atlanta, Georgia. Kidneys excrete waste products,

0:10:13.080 --> 0:10:17.200
<v Speaker 1>and they get rid of excess fluid from our bodies,

0:10:17.840 --> 0:10:21.640
<v Speaker 1>so that's what the dialysis machine does. Two needles are

0:10:21.640 --> 0:10:24.720
<v Speaker 1>inserted into a patient's arm. One draws blood out and

0:10:24.760 --> 0:10:27.360
<v Speaker 1>sends it through the machine to be cleaned. The other

0:10:27.400 --> 0:10:30.720
<v Speaker 1>needle returns the clean blood back into the patient, which

0:10:30.760 --> 0:10:33.920
<v Speaker 1>is pretty much exactly the way our kidneys work, except

0:10:34.120 --> 0:10:36.680
<v Speaker 1>while your kidneys work slowly, twenty four hours a day,

0:10:36.760 --> 0:10:40.000
<v Speaker 1>seven days a week. Dialysis means sitting in a chair

0:10:40.320 --> 0:10:42.600
<v Speaker 1>plugged into a machine for two to three hours at

0:10:42.640 --> 0:10:46.400
<v Speaker 1>a time, three times a week. It works, but it's

0:10:46.400 --> 0:10:50.439
<v Speaker 1>not ideal if you really think about it. We go

0:10:50.600 --> 0:10:54.280
<v Speaker 1>to the bathroom excrete our urine two or three four

0:10:54.320 --> 0:10:59.000
<v Speaker 1>times or more a day, so when patients are on dialysis,

0:10:59.000 --> 0:11:03.080
<v Speaker 1>they're really getting their blood clans just three days a

0:11:03.160 --> 0:11:07.640
<v Speaker 1>week for a few hours. And so patients can feel

0:11:08.160 --> 0:11:11.600
<v Speaker 1>washed out when they get off of dialysis because they've

0:11:11.600 --> 0:11:14.679
<v Speaker 1>had all this fluid from two days worth of not

0:11:15.040 --> 0:11:20.320
<v Speaker 1>excreting any waste products or fluid. There's no cure available

0:11:20.360 --> 0:11:23.840
<v Speaker 1>for chronic kidney disease. The medications currently on the market

0:11:24.000 --> 0:11:28.000
<v Speaker 1>focus on making sure a person's kidneys don't deteriorate further.

0:11:28.600 --> 0:11:33.559
<v Speaker 1>The current options include medications that suppress the immune system, diuretics,

0:11:33.720 --> 0:11:37.400
<v Speaker 1>ace inhibitors or a r B medications to control blood pressure,

0:11:37.480 --> 0:11:41.800
<v Speaker 1>or lower urine protein anticoagulants to prevent blood clots. And

0:11:41.840 --> 0:11:44.440
<v Speaker 1>then there's the option. Alonso Morning had done for his

0:11:44.640 --> 0:11:48.640
<v Speaker 1>f s GS a kidney transplant that approach requires you

0:11:48.720 --> 0:11:52.120
<v Speaker 1>to be fortunate enough to find a suitable donor. On average,

0:11:52.280 --> 0:11:58.600
<v Speaker 1>it also only last ten to twelve years. Vertex Pharmaceuticals

0:11:58.679 --> 0:12:00.839
<v Speaker 1>is a company that has researched ing a poll one

0:12:00.960 --> 0:12:04.360
<v Speaker 1>mediated kidney disease and other tough diseases where there's a

0:12:04.480 --> 0:12:07.880
<v Speaker 1>huge unmet need. They are targeting conditions where the human

0:12:07.880 --> 0:12:11.840
<v Speaker 1>biology is understood, the technology already exists, or Vertex thinks

0:12:11.840 --> 0:12:14.280
<v Speaker 1>that can develop it, and where Vertex has an approach

0:12:14.440 --> 0:12:18.000
<v Speaker 1>they think maybe transformative. They have several programs in their

0:12:18.000 --> 0:12:25.120
<v Speaker 1>investigational research, including a poll one mediated kidney disease. Dr

0:12:25.160 --> 0:12:28.440
<v Speaker 1>Ogo ed Buna leads clinical development for the team researching

0:12:28.520 --> 0:12:31.680
<v Speaker 1>kidney disease at Vertex. As we speak here in the US,

0:12:31.760 --> 0:12:35.320
<v Speaker 1>there are probably more than a hundred thousand people waiting

0:12:35.360 --> 0:12:38.840
<v Speaker 1>for a kidney, and not everyone is fortunate to be

0:12:38.880 --> 0:12:41.440
<v Speaker 1>able to get one. Many people will die waiting for

0:12:41.520 --> 0:12:44.400
<v Speaker 1>a kidney. The staggering number of people living with and

0:12:44.480 --> 0:12:46.840
<v Speaker 1>dying from kidney disease is one of the main reasons

0:12:46.840 --> 0:12:50.800
<v Speaker 1>why Dr ed Buna joined Vertexas efforts. It was really heartbreaking,

0:12:51.120 --> 0:12:53.480
<v Speaker 1>you know, at the beginning of the year, I'd have

0:12:54.080 --> 0:12:57.319
<v Speaker 1>a whole host of patients on theiralysis and at the

0:12:57.440 --> 0:13:00.720
<v Speaker 1>end of the year, one or two of every three

0:13:01.080 --> 0:13:05.680
<v Speaker 1>would have you know, costa. That was just too depressing

0:13:05.760 --> 0:13:09.520
<v Speaker 1>for me. Why did Vertex choose to focus on a

0:13:09.679 --> 0:13:14.040
<v Speaker 1>pole one versus other types of kidney disease? This is

0:13:14.080 --> 0:13:18.840
<v Speaker 1>actually one of the most difficult kidney diseases that have

0:13:19.200 --> 0:13:24.959
<v Speaker 1>lagged a minority population and underserved population for so long,

0:13:25.080 --> 0:13:29.360
<v Speaker 1>and for the longest time we have attributed this to

0:13:29.920 --> 0:13:33.920
<v Speaker 1>either bad diet or lack of exercise or nutrition. But

0:13:34.040 --> 0:13:38.320
<v Speaker 1>we do know now that there is a genetic basis

0:13:38.400 --> 0:13:40.960
<v Speaker 1>for a lot of this disparity. And I think in

0:13:41.320 --> 0:13:45.800
<v Speaker 1>typical Vertex fashion, we go after diseases that have a

0:13:45.880 --> 0:13:49.200
<v Speaker 1>serious and met need, and in addition to that, we

0:13:49.280 --> 0:13:54.080
<v Speaker 1>go after diseases where the underlying cause is well understood

0:13:54.280 --> 0:13:57.920
<v Speaker 1>and for which we apply, you know, the best science

0:13:57.920 --> 0:14:00.000
<v Speaker 1>available to try and address it. What can we look

0:14:00.080 --> 0:14:02.560
<v Speaker 1>forward to. Part of the reason why I'm actually so

0:14:02.600 --> 0:14:05.400
<v Speaker 1>excited about what we're doing here at Vertex is because

0:14:05.640 --> 0:14:11.200
<v Speaker 1>we have found small molecule therapies that are investigational to

0:14:11.360 --> 0:14:14.640
<v Speaker 1>the underlying cause of what I've described as april and

0:14:14.679 --> 0:14:19.200
<v Speaker 1>one media to kidney disease. We have evaluated these potential

0:14:19.240 --> 0:14:23.760
<v Speaker 1>therapies in experimental settings and first in human studies as

0:14:23.800 --> 0:14:27.680
<v Speaker 1>well as a preliminary proof of concept study in patients.

0:14:29.920 --> 0:14:33.320
<v Speaker 1>Developing a potential small molecule therapy is no easy feat.

0:14:33.720 --> 0:14:36.640
<v Speaker 1>Dr ed Buna says scientists a Vertex have gone through

0:14:36.800 --> 0:14:41.000
<v Speaker 1>hundreds of thousands of candidate molecules and their kidney disease research.

0:14:41.960 --> 0:14:46.320
<v Speaker 1>Nothing good or great comes easy. Therein lies the promise

0:14:46.400 --> 0:14:50.560
<v Speaker 1>and the excitement well the research continues. Dr ed Bunah

0:14:50.600 --> 0:14:53.200
<v Speaker 1>says he and his team at Vertex will do everything

0:14:53.240 --> 0:14:56.240
<v Speaker 1>they can to raise awareness for the disease. That includes

0:14:56.360 --> 0:14:59.880
<v Speaker 1>educating on preventative measures like genotyping, which can help the

0:15:00.040 --> 0:15:04.120
<v Speaker 1>ternaman whether a patient carries the A L one genetic variant. So,

0:15:04.160 --> 0:15:08.000
<v Speaker 1>in addition to supporting the clinical community and patients in

0:15:08.000 --> 0:15:11.160
<v Speaker 1>increasing the rates of diagnosis of kidney disease, we also

0:15:11.240 --> 0:15:16.040
<v Speaker 1>want an increase in the awareness and of genotyping so

0:15:16.080 --> 0:15:19.040
<v Speaker 1>that precise diagnosis can be made so that the right

0:15:19.120 --> 0:15:22.520
<v Speaker 1>therapy can be brought to the patient. Alonso Morning is

0:15:22.560 --> 0:15:25.720
<v Speaker 1>one of those great examples of people that went through

0:15:26.120 --> 0:15:30.640
<v Speaker 1>the science symptoms, the worries, the challenges of stage advanced

0:15:30.720 --> 0:15:33.960
<v Speaker 1>kidney disease, got a transplant, and he got back on

0:15:34.040 --> 0:15:41.040
<v Speaker 1>his feet. Alonso Morning underwent a kidney transplant three years

0:15:41.080 --> 0:15:46.040
<v Speaker 1>after his initial diagnosis. So the recovery process was grueling

0:15:46.720 --> 0:15:50.800
<v Speaker 1>and it was extremely painful at times, and it was difficult.

0:15:51.320 --> 0:15:53.880
<v Speaker 1>But if you think about anything in life worth having,

0:15:54.440 --> 0:15:57.160
<v Speaker 1>is very difficult to get it. And I was trying

0:15:57.200 --> 0:15:58.840
<v Speaker 1>to get my help back, and I was trying to

0:15:58.880 --> 0:16:01.440
<v Speaker 1>get back on the court, So I was trying to

0:16:01.480 --> 0:16:04.400
<v Speaker 1>get back to some sense of normalcy. But it challenged

0:16:04.440 --> 0:16:09.040
<v Speaker 1>me tremendously, and it really truly challenged me. Morning talks

0:16:09.080 --> 0:16:11.520
<v Speaker 1>about his struggle to get and then adapt to living

0:16:11.520 --> 0:16:14.320
<v Speaker 1>with a new kidney, knowing full well that he had

0:16:14.320 --> 0:16:19.320
<v Speaker 1>a lot of advantages that was in optimal condition, excellent health,

0:16:19.400 --> 0:16:23.720
<v Speaker 1>you know. But that was the benefit of my recovery

0:16:24.440 --> 0:16:28.360
<v Speaker 1>so fast, because the doctors told me, like, hey, you know,

0:16:28.680 --> 0:16:33.280
<v Speaker 1>if you wasn't his high performance athlete, then you probably

0:16:33.320 --> 0:16:37.200
<v Speaker 1>wouldn't have bounced back as fast after the transplant, and

0:16:37.240 --> 0:16:40.840
<v Speaker 1>bounce back he did just three years after his transplant

0:16:40.880 --> 0:16:43.480
<v Speaker 1>alongso Morning would go on and win a championship with

0:16:43.520 --> 0:16:46.720
<v Speaker 1>the Miami Heat in two thousand six, and today he's

0:16:46.760 --> 0:16:50.320
<v Speaker 1>partnering with Vertex as a spokesperson, using his profile and

0:16:50.360 --> 0:16:54.040
<v Speaker 1>his experience to advocate and educate. You know, a big

0:16:54.080 --> 0:16:57.920
<v Speaker 1>part of it is to try to inspire and provide

0:16:57.960 --> 0:17:01.800
<v Speaker 1>hope and encouragement for those who are going through the

0:17:01.840 --> 0:17:05.399
<v Speaker 1>same ordeal. And Morning says he's hoping Vertex will be

0:17:05.440 --> 0:17:08.560
<v Speaker 1>able to help kidney patients by raising awareness of the disease,

0:17:08.880 --> 0:17:12.280
<v Speaker 1>encouraging people to visit their doctor, and continuing to search

0:17:12.400 --> 0:17:15.960
<v Speaker 1>for a potential treatment. So if this can happen, then

0:17:16.680 --> 0:17:20.600
<v Speaker 1>all of what I've gone through is so much more

0:17:20.640 --> 0:17:26.000
<v Speaker 1>of a worthwhile because maybe to help save other people's lives.

0:17:36.520 --> 0:17:39.640
<v Speaker 1>This is targeting the toughest diseases. A podcast from Bloomberg

0:17:39.640 --> 0:17:43.400
<v Speaker 1>Media Studios and Vertex Pharmaceuticals. If you like what you hear,

0:17:43.720 --> 0:17:47.320
<v Speaker 1>subscribe and leave us a review. I'm Jordan's Gospel. Thanks

0:17:47.400 --> 0:17:47.919
<v Speaker 1>for listening.